Black Men Have Lower Rates Than White Men of Biochemical Failure with Primary Androgen-Deprivation Therapy
- 1 September 2011
- journal article
- Published by The Permanente Federation in The Permanente Journal
- Vol. 15 (3) , 4-8
Abstract
Pejvak Sassani, MD; Jeremy M Blumberg, MD; T Craig Cheetham, PharmD, MS; Fang Niu; Stephen G Williams, MD; Gary W Chien, MD Summer 2011 - Volume 15 Number 3 Abstract Introduction: Black men have a higher incidence of advanced stage at diagnosisKeywords
This publication has 22 references indexed in Scilit:
- Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate CancerJournal of Clinical Oncology, 2009
- Determining Dosing Intervals for Luteinizing Hormone Releasing Hormone Agonists Based on Serum Testosterone Levels: A Prospective StudyJournal of Urology, 2007
- Black Race Does Not Independently Predict Adverse Outcome Following Radical Retropubic Prostatectomy at a Tertiary Referral CenterJournal of Urology, 2006
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Factors contributing to the racial differences in prostate cancer mortalityBJU International, 2005
- Racial Differences in Prostate Cancer Treatment OutcomesCancer Nursing, 2005
- Racial Differences in Androgen Receptor Protein Expression in Men With Clinically Localized Prostate CancerJournal of Urology, 2003
- Prostate Specific Antigen in Black and White Men After Hormonal Therapies for Prostate CancerJournal of Urology, 1997
- Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancerClinical Therapeutics, 1996
- Endocrine Control of Prostatic CancerScience, 1943